Wilson JM - Search Results

1

Efficacy and Safety of a Krabbe Disease Gene Therapy.

Hordeaux J, Jeffrey BA, Jian J, Choudhury GR, Michalson K, Mitchell TW, Buza EL, Chichester J, Dyer C, Bagel J, Vite CH, Bradbury AM, Wilson JM. Hordeaux J, et al. Among authors: wilson jm. Hum Gene Ther. 2022 May;33(9-10):499-517. doi: 10.1089/hum.2021.245. Epub 2022 Mar 22. Hum Gene Ther. 2022. PMID: 35333110 Free PMC article.

2

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Engelhardt JF, Simon RH, Yang Y, Zepeda M, Weber-Pendleton S, Doranz B, Grossman M, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Hum Gene Ther. 1993 Dec;4(6):759-69. doi: 10.1089/hum.1993.4.6-759. Hum Gene Ther. 1993. PMID: 7514445 Free article.

3

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.

Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM. Goldman MJ, et al. Among authors: wilson jm. Hum Gene Ther. 1995 Jul;6(7):839-51. doi: 10.1089/hum.1995.6.7-839. Hum Gene Ther. 1995. PMID: 7578403

4

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

Engelhardt JF, Litzky L, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Hum Gene Ther. 1994 Oct;5(10):1217-29. doi: 10.1089/hum.1994.5.10-1217. Hum Gene Ther. 1994. PMID: 7849095

5

Animal models of human disease for gene therapy.

Wilson JM. Wilson JM. J Clin Invest. 1996 Mar 1;97(5):1138-41. doi: 10.1172/JCI118527. J Clin Invest. 1996. PMID: 8636424 Free PMC article. No abstract available.

6

Gene therapy: socioeconomic and ethical issues. A roundtable discussion.

Hillman AL, Brenner MK, Caplan AL, Carey J, Champey Y, Culver KW, Drummond MF, Freund DA, Holmes EW, Kelley WN, Kolata G, Levine MN, Levy E, Schondelmeyer SW, Velu T, Wilson JM. Hillman AL, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Jun 10;7(9):1139-44. doi: 10.1089/hum.1996.7.9-1139. Hum Gene Ther. 1996. PMID: 8773516

7

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM. Eck SL, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Aug 1;7(12):1465-82. doi: 10.1089/hum.1996.7.12-1465. Hum Gene Ther. 1996. PMID: 8844206 Clinical Trial.

8

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

Jooss K, Yang Y, Wilson JM. Jooss K, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Aug 20;7(13):1555-66. doi: 10.1089/hum.1996.7.13-1555. Hum Gene Ther. 1996. PMID: 8864756

9

Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis.

Goldman M, Su Q, Wilson JM. Goldman M, et al. Among authors: wilson jm. Gene Ther. 1996 Sep;3(9):811-8. Gene Ther. 1996. PMID: 8875230

10

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.

Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DB, Greelish JP, Mitchell MA, Wells A, Sweeney HL, Wilson JM. Haecker SE, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Oct 1;7(15):1907-14. doi: 10.1089/hum.1996.7.15-1907. Hum Gene Ther. 1996. PMID: 8894682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,855 results

Search Page

Filters